Using a cohort of 95 patients with oropharyngeal squamous cell carcinomas, Psyrri et al (2005) found that both total and nuclear EGFR levels predict poor clinical outcomes as measured by local recurrence and poor disease-free survival. This evidence concerns the gene EGFR and oropharynx squamous cell carcinoma.